Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06245915
Title AB-2100, an Integrated Circuit T (ICT) Cell Therapy in Patients With Recurrent Clear-cell Renal Cell Carcinoma (ccRCC)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Arsenal Biosciences, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope RECRUITING Duarte California 91010 United States Details
University of Iowa and Holden Comprehensive Cancer Center RECRUITING Iowa City Iowa 52242 United States Details
Dana Farber Cancer Institue RECRUITING Boston Massachusetts 02215 United States Details
Memorial Sloan Kettering Cancer Center RECRUITING New York City New York 10065 United States Details
Perlmutter Cancer Center - NYU Langone Health RECRUITING New York New York 10016 United States Details
MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
Huntsman Cancer Institute - Univ of Utah Health RECRUITING Salt Lake City Utah 84112 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field